Novel therapeutic approaches to xeroderma pigmentosum

J. L. Weon, Donald A Glass

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: The study of xeroderma pigmentosum has yielded unforeseen advances regarding how defects in the nucleotide excision repair pathway result in this devastating disease, but development of therapeutic strategies has trailed behind the mechanistic discoveries. Objectives: This review aims to cover clinical presentation, molecular mechanisms and current management, and highlights more recent insights into targeting the deficiencies secondary to the DNA repair defects to prevent skin cancer and/or neurological degeneration. Methods: This review article discusses novel therapeutic approaches to xeroderma pigmentosum that focus on metabolic defects downstream of nucleotide excision repair. Results: Current research demonstrates that specific sulfonylureas promote clearance of DNA damage and increase resistance to ultraviolet radiation in a cellular model of xeroderma pigmentosum. Moreover, nicotinamide attenuates the effects of ultraviolet radiation in cells, and caloric restriction decreases DNA damage burden in animal models of xeroderma pigmentosum. Conclusions: Clinical management of patients with xeroderma pigmentosum still focuses on preventative avoidance of sun exposure as opposed to therapies that would improve the patients’ condition; thus, novel approaches to this disease are warranted.

Original languageEnglish (US)
JournalBritish Journal of Dermatology
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Xeroderma Pigmentosum
DNA Repair
DNA Damage
Therapeutics
Caloric Restriction
Niacinamide
Radiation Effects
Skin Neoplasms
Solar System
Animal Models
Radiation
Research

ASJC Scopus subject areas

  • Dermatology

Cite this

Novel therapeutic approaches to xeroderma pigmentosum. / Weon, J. L.; Glass, Donald A.

In: British Journal of Dermatology, 01.01.2018.

Research output: Contribution to journalArticle

@article{dadb1a889f8e4cb2abdea63cabe32bd0,
title = "Novel therapeutic approaches to xeroderma pigmentosum",
abstract = "Background: The study of xeroderma pigmentosum has yielded unforeseen advances regarding how defects in the nucleotide excision repair pathway result in this devastating disease, but development of therapeutic strategies has trailed behind the mechanistic discoveries. Objectives: This review aims to cover clinical presentation, molecular mechanisms and current management, and highlights more recent insights into targeting the deficiencies secondary to the DNA repair defects to prevent skin cancer and/or neurological degeneration. Methods: This review article discusses novel therapeutic approaches to xeroderma pigmentosum that focus on metabolic defects downstream of nucleotide excision repair. Results: Current research demonstrates that specific sulfonylureas promote clearance of DNA damage and increase resistance to ultraviolet radiation in a cellular model of xeroderma pigmentosum. Moreover, nicotinamide attenuates the effects of ultraviolet radiation in cells, and caloric restriction decreases DNA damage burden in animal models of xeroderma pigmentosum. Conclusions: Clinical management of patients with xeroderma pigmentosum still focuses on preventative avoidance of sun exposure as opposed to therapies that would improve the patients’ condition; thus, novel approaches to this disease are warranted.",
author = "Weon, {J. L.} and Glass, {Donald A}",
year = "2018",
month = "1",
day = "1",
doi = "10.1111/bjd.17253",
language = "English (US)",
journal = "British Journal of Dermatology",
issn = "0007-0963",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Novel therapeutic approaches to xeroderma pigmentosum

AU - Weon, J. L.

AU - Glass, Donald A

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Background: The study of xeroderma pigmentosum has yielded unforeseen advances regarding how defects in the nucleotide excision repair pathway result in this devastating disease, but development of therapeutic strategies has trailed behind the mechanistic discoveries. Objectives: This review aims to cover clinical presentation, molecular mechanisms and current management, and highlights more recent insights into targeting the deficiencies secondary to the DNA repair defects to prevent skin cancer and/or neurological degeneration. Methods: This review article discusses novel therapeutic approaches to xeroderma pigmentosum that focus on metabolic defects downstream of nucleotide excision repair. Results: Current research demonstrates that specific sulfonylureas promote clearance of DNA damage and increase resistance to ultraviolet radiation in a cellular model of xeroderma pigmentosum. Moreover, nicotinamide attenuates the effects of ultraviolet radiation in cells, and caloric restriction decreases DNA damage burden in animal models of xeroderma pigmentosum. Conclusions: Clinical management of patients with xeroderma pigmentosum still focuses on preventative avoidance of sun exposure as opposed to therapies that would improve the patients’ condition; thus, novel approaches to this disease are warranted.

AB - Background: The study of xeroderma pigmentosum has yielded unforeseen advances regarding how defects in the nucleotide excision repair pathway result in this devastating disease, but development of therapeutic strategies has trailed behind the mechanistic discoveries. Objectives: This review aims to cover clinical presentation, molecular mechanisms and current management, and highlights more recent insights into targeting the deficiencies secondary to the DNA repair defects to prevent skin cancer and/or neurological degeneration. Methods: This review article discusses novel therapeutic approaches to xeroderma pigmentosum that focus on metabolic defects downstream of nucleotide excision repair. Results: Current research demonstrates that specific sulfonylureas promote clearance of DNA damage and increase resistance to ultraviolet radiation in a cellular model of xeroderma pigmentosum. Moreover, nicotinamide attenuates the effects of ultraviolet radiation in cells, and caloric restriction decreases DNA damage burden in animal models of xeroderma pigmentosum. Conclusions: Clinical management of patients with xeroderma pigmentosum still focuses on preventative avoidance of sun exposure as opposed to therapies that would improve the patients’ condition; thus, novel approaches to this disease are warranted.

UR - http://www.scopus.com/inward/record.url?scp=85057139275&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057139275&partnerID=8YFLogxK

U2 - 10.1111/bjd.17253

DO - 10.1111/bjd.17253

M3 - Article

C2 - 30265743

AN - SCOPUS:85057139275

JO - British Journal of Dermatology

JF - British Journal of Dermatology

SN - 0007-0963

ER -